<i>Ex Vivo</i> Regional Gene Therapy Compared to Recombinant BMP-2 for the Treatment of Critical-Size Bone Defects: An In Vivo Single-Cell RNA-Sequencing Study

<i>Ex Vivo</i> Regional Gene Therapy Compared to Recombinant BMP-2 for the Treatment of Critical-Size Bone Defects: An In Vivo Single-Cell RNA-Sequencing Study

<i>Ex vivo</i> regional gene therapy is a promising tissue-engineering strategy for bone regeneration: osteogenic mesenchymal stem cells (MSCs) can be genetically modified to express an osteoinductive stimulus (e.g., bone morphogenetic protein-2), seeded onto an osteoconductive scaffold,...

Full description

Saved in:
Bibliographic Details
Main Authors: Arijita Sarkar, Matthew C. Gallo, Jennifer A. Bell, Cory K. Mayfield, Jacob R. Ball, Mina Ayad, Elizabeth Lechtholz-Zey, Stephanie W. Chang, Osamu Sugiyama, Denis Evseenko, Jay R. Lieberman
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Bioengineering
Subjects:
single-cell RNA sequencing
gene therapy
BMP-2
mesenchymal stem cells
endochondral ossification
inflammation
Online Access:https://www.mdpi.com/2306-5354/12/1/29
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items